The FDA has issued several guidance documents to help industry navigate the regulatory landscape of nanotechnology. These documents provide recommendations on:
Conducting safety assessments for nanomaterials used in food and cosmetics. Designing and conducting preclinical and clinical studies for nanomedicines. Ensuring the quality and consistency of nanotechnology-based products. Communicating the benefits and risks of nanotechnology to consumers.
